2023
DOI: 10.1016/j.addr.2023.115086
|View full text |Cite
|
Sign up to set email alerts
|

Safety of surfactant excipients in oral drug formulations

Sam Maher,
Caroline Geoghegan,
David J. Brayden
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 323 publications
0
2
0
Order By: Relevance
“…By adding a phosphanium chain to caffeic acid, we prepared four substances with surfactant properties. Surfactants as pharmaceuticals are well-known for topical application, although some surfactants within acceptable dose limits are considered safe for human consumption and could be used in oral pharmaceutical products [46]. According to our results, the prepared caffeic acid phosphanium derivatives exhibited a high cytotoxic effect against the control cell line.…”
Section: Anti-acanthamoeba Activitymentioning
confidence: 63%
“…By adding a phosphanium chain to caffeic acid, we prepared four substances with surfactant properties. Surfactants as pharmaceuticals are well-known for topical application, although some surfactants within acceptable dose limits are considered safe for human consumption and could be used in oral pharmaceutical products [46]. According to our results, the prepared caffeic acid phosphanium derivatives exhibited a high cytotoxic effect against the control cell line.…”
Section: Anti-acanthamoeba Activitymentioning
confidence: 63%
“…The selection of surfactants was informed by a thorough literature evaluation of their safety profiles, effectiveness in nanoparticle stabilization, and the possibility of enhancing the absorption of CBD. Such criteria ensured our formulation's alignment with the existing literature on oral applications [37][38][39].…”
Section: Particle Size (Ymentioning
confidence: 99%